LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,960 | -91.6% | 97,211 | -82.3% | 0.00% | – |
| Q2 2023 | $1,254,734 | +192.0% | 547,919 | +209.9% | 0.00% | – |
| Q1 2023 | $429,695 | +16.6% | 176,829 | -8.4% | 0.00% | – |
| Q4 2022 | $368,584 | +2.4% | 192,976 | +28.9% | 0.00% | – |
| Q3 2022 | $360,000 | -17.1% | 149,693 | -35.7% | 0.00% | – |
| Q2 2022 | $434,000 | -56.0% | 232,979 | -50.6% | 0.00% | – |
| Q1 2022 | $987,000 | +151.1% | 471,812 | +372.5% | 0.00% | – |
| Q4 2021 | $393,000 | -32.1% | 99,846 | -17.2% | 0.00% | – |
| Q3 2021 | $579,000 | +32.2% | 120,556 | +26.5% | 0.00% | – |
| Q2 2021 | $438,000 | -70.4% | 95,333 | -62.2% | 0.00% | – |
| Q1 2021 | $1,481,000 | +456.8% | 252,192 | +224.2% | 0.00% | – |
| Q4 2020 | $266,000 | +171.4% | 77,800 | +13.9% | 0.00% | – |
| Q3 2020 | $98,000 | +157.9% | 68,300 | +261.4% | 0.00% | – |
| Q2 2020 | $38,000 | -82.2% | 18,900 | -82.7% | 0.00% | – |
| Q1 2020 | $213,000 | -85.8% | 108,983 | -69.8% | 0.00% | -100.0% |
| Q4 2019 | $1,497,000 | +98.8% | 360,812 | +44.3% | 0.00% | – |
| Q3 2019 | $753,000 | -79.5% | 250,068 | -57.1% | 0.00% | -100.0% |
| Q2 2019 | $3,665,000 | +1.6% | 582,547 | -10.2% | 0.00% | 0.0% |
| Q1 2019 | $3,608,000 | +40.9% | 648,827 | +68.3% | 0.00% | +100.0% |
| Q4 2018 | $2,560,000 | +248.8% | 385,422 | +460.1% | 0.00% | – |
| Q3 2018 | $734,000 | -62.5% | 68,812 | -57.8% | 0.00% | -100.0% |
| Q2 2018 | $1,956,000 | +76.1% | 163,019 | +25.8% | 0.00% | 0.0% |
| Q1 2018 | $1,111,000 | -38.2% | 129,621 | -28.8% | 0.00% | 0.0% |
| Q4 2017 | $1,799,000 | +51.3% | 182,174 | +88.4% | 0.00% | 0.0% |
| Q3 2017 | $1,189,000 | -42.2% | 96,706 | -22.7% | 0.00% | -50.0% |
| Q2 2017 | $2,058,000 | +1162.6% | 125,126 | +997.6% | 0.00% | – |
| Q1 2017 | $163,000 | -36.6% | 11,400 | -38.6% | 0.00% | – |
| Q4 2016 | $257,000 | +23.6% | 18,570 | +61.5% | 0.00% | – |
| Q3 2016 | $208,000 | -70.7% | 11,500 | -80.7% | 0.00% | -100.0% |
| Q1 2016 | $711,000 | +257.3% | 59,524 | +298.4% | 0.00% | – |
| Q4 2015 | $199,000 | +352.3% | 14,940 | +264.9% | 0.00% | – |
| Q3 2015 | $44,000 | -84.5% | 4,094 | -88.4% | 0.00% | – |
| Q2 2015 | $283,000 | – | 35,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |